Myocardial performance and extracellular ionized calcium in a severely failing human heart

Insights

In severe heart failure, beta-agonist drugs may fail due to receptor loss. Calcium levels then become critical for heart muscle function, offering a potential treatment target.

Area of Science:

  • Cardiology
  • Pharmacology
  • Biochemistry

Background:

  • Investigated a 16-year-old patient with end-stage congestive heart failure unresponsive to beta-agonist therapy.
  • Addressed critically low serum ionized calcium (Ca2+) levels, which were corrected with calcium chloride (CaCl2) infusions.

Observation:

  • Myocardial performance demonstrated a direct correlation with serum Ca2+ levels.
  • In vitro studies of the explanted heart revealed subsensitivity to isoproterenol and near-complete absence of beta-adrenergic receptors.
  • Papillary muscles responded normally to calcium, and other cellular signaling pathways (adenylate cyclase) were unaffected.

Findings:

  • Beta-adrenergic receptor down-regulation was identified as the cause of beta-agonist ineffectiveness.
  • Myocardial contractility was found to be dependent on extracellular calcium levels in this specific condition.

Implications:

  • Suggests that in cases of beta-adrenergic receptor down-regulation, calcium levels are crucial for maintaining cardiac contractility.
  • Highlights a potential therapeutic strategy focusing on calcium modulation when beta-agonists are ineffective in heart failure.